Previous close | 0.8700 |
Open | 1.4000 |
Bid | 1.0300 |
Ask | 1.2900 |
Strike | 43.00 |
Expiry date | 2024-08-16 |
Day's range | 1.0200 - 1.4000 |
Contract range | N/A |
Volume | |
Open interest | 3.08k |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024